Reference data : LOINC code

Filter

Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType		Clear filter
AND
Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType
AND
Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType

Results

104,672 results found

• First page
• Previous page
• /4187
• Next page
• Last page

Loinc Number	Component	Property	System	Time aspect	ScaleType	MethodType	Relat_nms	loincStatus	Long Common name	answerList	chngType	DefinitionDescription	dtLastCh	exactCmspy	exampleUnits	exmplAnswers	externalCopyrightNotice	formula	hl7FieldSubfieldId	InpcPercentage	ipccUnits	loincClass	loincFinal	loincNum	mapTo	methodTyp	molarMass	naaccrId	orderObs	panelElements	reference	scope	setRoot	shortName	source	surveyQuestSrc	surveyQuestText	unitsRequired	acssym	relatedNames2	VersionLastChanged	VersionFirstRelease	ValidHL7AttachmentRequest	PanelType	AssociatedObservations	EXTERNAL_COPYRIGHT_LINK	HL7_ATTACHMENT_STRUCTURE	CONSUMER_NAME	EXAMPLE_UCUM_UNITS	STATUS_REASON	STATUS_TEXT	CHANGE_REASON_PUBLIC	COMMON_TEST_RANK	COMMON_ORDER_RANK
51410-9	Environmental stressors panel	-	Water	Pt	-			ACTIVE	Environmental stressors panel - Water		MIN	DefinitionDescription										PANEL.DRUG/TOX		51410-9					Order				0	Envir stressors Pnl Wat				N		DRUG/TOXICOLOGY; Drugs; Envir stressors Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Wat	2.42	2.22		Panel										0
51411-7	Environmental stressors panel	-	Air	Pt	-			ACTIVE	Environmental stressors panel - Air		MIN	DefinitionDescription										PANEL.DRUG/TOX		51411-7					Order				0	Envir stressors Pnl Air				N		DRUG/TOXICOLOGY; Drugs; Envir stressors Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random	2.42	2.22		Panel										0
51412-5	3-Hydroxyisovalerylcarnitine+2-Methyl,3-Hydroxybutyrylcarnitine (C5-OH)	SCnc	Ser/Plas	Pt	Qn			ACTIVE	3-Hydroxyisovalerylcarnitine+2-Methyl,3-Hydroxybutyrylcarnitine (C5-OH) [Moles/volume] in Serum or Plasma		MIN	DefinitionDescription			umol/L							CHEM		51412-5					Both				0	3OH-IV+2Me3OH-Butyr carn SerPl-sCnc				N		2Me3OH-Butyrcarn; 3OH-IV+2Me3OH-Butyr carn; Chemistry; II; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.73	2.22								umol/L				0
51413-3	Butyrylcarnitine+Isobutyrylcarnitine (C4)	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in Serum or Plasma		MIN	DefinitionDescription			umol/L							CHEM		51413-3					Both				0	Butyryl+Isobutyrylcarn SerPl-sCnc				N		Butyryl+Isobutyrylcarn; C4; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.73	2.22								umol/L				0
51414-1	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Serum or Plasma		MIN	DefinitionDescription			umol/L							CHEM		51414-1					Both				0	Glut+3OHdecanoylcarn SerPl-sCnc				N		3-OH-decanoylcarn; C10OH; C10-OH; C5DC; C5-DC; Chemistry; Dicarboxylic carnitine; Glut+3OHdecanoylcarn; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.22								umol/L				0
51415-8	Methylmalonylcarnitine+Succinylcarnitine (C4-DC)	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Methylmalonylcarnitine+Succinylcarnitine (C4-DC) [Moles/volume] in Serum or Plasma		MIN	DefinitionDescription			umol/L							CHEM		51415-8					Both				0	Me-malonylcarn+Succinylcarn SerPl-sCnc				N		C4DC; C4-DC; C4-DCC; Chemistry; Dicarboxylic carnitine; Level; Me-malonylcarn+Succinylcarn; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.22								umol/L				0
51416-6	Tiglylcarnitine (C5:1)	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Tiglylcarnitine (C5:1) [Moles/volume] in Serum or Plasma		MIN	DefinitionDescription			umol/L							CHEM		51416-6					Both				0	Tiglylcarn SerPl-sCnc				N		(C5:1); C5:1; Chemistry; i; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.22								umol/L				0
51417-4	Coproporphyrin/Porphyrins.total	SFr	Urine	24H	Qn			ACTIVE	Coproporphyrin/Porphyrins.total in 24 hour Urine		MIN	DefinitionDescription			%							CHEM		51417-4					Observation				0	Copro 24h SFr Ur				N		1 day; 24 hours; 24HR; Chemistry; Copro; Coproporph; Coproporphyrins; Hematology; Heme; Percent; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Substance Fraction; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; Tot; Totl; UA; UR; Urn	2.7	2.22								%				0
51418-2	Domperidone	SCnc	Body fld	Pt	Qn			ACTIVE	Domperidone [Moles/volume] in Body fluid		MIN	DefinitionDescription			nmol/L							DRUG/TOX		51418-2					Both				0	Domperidone Fld-sCnc				N		B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Costi; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Motilium; Motillium; Motinorm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	2.7	2.22								nmol/L				0
51419-0	Sodium^^corrected for glucose	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Sodium [Moles/volume] corrected for glucose in Serum or Plasma		MIN	DefinitionDescription			mmol/L							CHEM		51419-0					Observation				0	Sodium Glucose cor SerPl-sCnc				N		Chemistry; Glu; Gluc; Glucose cor; Glucoseur; Level; Na; Na+; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.22								mmol/L				0
5142-5	Echovirus 4 Ab.Neut	Titr	Ser	Pt	SemiQn	Neut		ACTIVE	Echovirus 4 neutralizing antibody [Titer] in Serum by Neutralization test		MAJ	DefinitionDescription			titer							MICRO		5142-5		Neut			Both				0	ECV4 NAb Titr Ser Nt				Y		ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 4; ECV; ECV4; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT	2.75	1								{titer}			Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.;	0
51420-8	17-Hydroxyprogesterone^pre or post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		51420-8					Observation				0	17OHP pre/p chal SerPl-sCnc				N		17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.22								nmol/L				0
51421-6	Testosterone^pre or post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Testosterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		51421-6					Observation				0	Testost pre/p chal SerPl-sCnc				N		After; Before; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Testo; Testos; Testost	2.7	2.22								nmol/L				0
51422-4	Aldosterone^pre or post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Aldosterone [Moles/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			pmol/L							CHAL		51422-4					Observation				0	Aldost pre/p chal SerPl-sCnc				N		After; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.22								pmol/L				0
51423-2	Corticotropin^pre or post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Corticotropin [Moles/volume] in Plasma --pre or post XXX challenge		MIN	DefinitionDescription			pmol/L							CHAL		51423-2					Observation				0	ACTH pre/p chal Plas-sCnc				N		ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; Level; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; Substance concentration; Tumor marker	2.7	2.22								pmol/L				0
51424-0	Cortisol^pre or post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Cortisol [Moles/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		51424-0					Observation				0	Cortis pre/p chal SerPl-sCnc				N		17-Hydroxycorticosterone; After; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.22								nmol/L				0
51425-7	EPINEPHrine^pre or post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	EPINEPHrine [Moles/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		51425-7					Observation				0	Epineph pre/p chal SerPl-sCnc				N		Adrenalin; Adrenaline; Adreneline; After; Before; CHEMISTRY.CHALLENGE TESTING; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Level; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.73	2.22								nmol/L				0
51426-5	Glucose^pre or post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Glucose [Moles/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		51426-5					Observation				0	Glucose pre/p chal SerPl-sCnc				N		After; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.22								mmol/L				0
51427-3	Insulin^pre or post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Insulin [Moles/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			pmol/L							CHAL		51427-3					Observation				0	Insulin pre/p chal SerPl-sCnc				N		After; Before; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	2.7	2.22								pmol/L				0
51428-1	Lactate^pre or post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Lactate [Moles/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		51428-1					Observation				0	Lactate pre/p chal SerPl-sCnc				N		2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; After; Before; CHEMISTRY.CHALLENGE TESTING; Lact; Lactic acid; Level; L-lactate; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.7	2.22								mmol/L				0
51429-9	Norepinephrine^pre or post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		51429-9					Observation				0	Norepineph pre/p chal SerPl-sCnc				N		After; Before; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.73	2.22								nmol/L				0
5143-3	Echovirus 4 Ab	Titr	Ser	Pt	SemiQn	Comp fix		ACTIVE	Echovirus 4 Ab [Titer] in Serum by Complement fixation		MAJ	DefinitionDescription			titer							MICRO		5143-3		Comp fix			Both				0	ECV4 Ab Titr Ser CF				Y		ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 4; ECV; ECV4; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	2.75	1								{titer}				0
51430-7	Calcitonin^pre or post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcitonin [Mass/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		51430-7					Observation				0	Calcit pre/p chal SerPl-mCnc				N		After; Before; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	2.7	2.22								pg/mL				0
51431-5	Gastrin^pre or post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Gastrin [Mass/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		51431-5					Observation				0	Gastrin pre/p chal SerPl-mCnc				N		After; Before; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome	2.7	2.22								pg/mL				0
51432-3	Prolactin^pre or post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Prolactin [Mass/volume] in Serum or Plasma --pre or post XXX challenge		MIN	DefinitionDescription			ng/mL;ug/L							CHAL		51432-3					Observation				0	Prolactin pre/p chal SerPl-mCnc				N		After; Before; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; pre/p chal; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	2.7	2.22								ng/mL				0

104,672 results found

• First page
• Previous page
• /4187
• Next page
• Last page